BIOMAT Database Logo BIOMAT Database Logo

Early Postoperative Thrombosis of Transcatheter Aortic Valve-in-Valve Prosthesis. 2021

Alessandra Francica, and Mikhail Dodonov, and Filippo Tonelli, and Gaetano Paolino, and Gabriele Pesarini, and Flavio Ribichini, and Giuseppe Faggian, and Francesco Onorati
Division of Cardiac Surgery, University of Verona Medical School, Verona, Italy. Electronic address: alessandrafrancica@yahoo.it.

Valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) has been popularized as an attractive alternative to redo surgical aortic valve replacement for bioprosthetic valve dysfunction. Acute valve thrombosis has been occasionally described after ViV-TAVR. Lack of anticoagulant therapy has been always considered a crucial risk factor. This report describes a rare case of early postoperative fatal ViV-TAVR thrombosis despite adequate anticoagulation in addition to dual antiplatelet therapy.

UI MeSH Term Description Entries
D008297 Male Males
D011474 Prosthesis Design The plan and delineation of prostheses in general or a specific prosthesis. Design, Prosthesis,Designs, Prosthesis,Prosthesis Designs
D011475 Prosthesis Failure Malfunction of implantation shunts, valves, etc., and prosthesis loosening, migration, and breaking. Prosthesis Loosening,Prosthesis Durability,Prosthesis Migration,Prosthesis Survival,Durabilities, Prosthesis,Durability, Prosthesis,Failure, Prosthesis,Failures, Prosthesis,Loosening, Prosthesis,Loosenings, Prosthesis,Migration, Prosthesis,Migrations, Prosthesis,Prosthesis Durabilities,Prosthesis Failures,Prosthesis Loosenings,Prosthesis Migrations,Prosthesis Survivals,Survival, Prosthesis,Survivals, Prosthesis
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D001021 Aortic Valve The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle. Aortic Valves,Valve, Aortic,Valves, Aortic
D001024 Aortic Valve Stenosis A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA. Aortic Stenosis,Aortic Valve Stenoses,Stenoses, Aortic,Stenoses, Aortic Valve,Stenosis, Aortic,Stenosis, Aortic Valve,Valve Stenoses, Aortic,Valve Stenosis, Aortic
D001705 Bioprosthesis Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers. Glutaraldehyde-Stabilized Grafts,Heterograft Bioprosthesis,Porcine Xenograft Bioprosthesis,Xenograft Bioprosthesis,Bioprostheses,Bioprostheses, Heterograft,Bioprostheses, Porcine Xenograft,Bioprostheses, Xenograft,Bioprosthesis, Heterograft,Bioprosthesis, Porcine Xenograft,Bioprosthesis, Xenograft,Glutaraldehyde Stabilized Grafts,Glutaraldehyde-Stabilized Graft,Graft, Glutaraldehyde-Stabilized,Grafts, Glutaraldehyde-Stabilized,Heterograft Bioprostheses,Porcine Xenograft Bioprostheses,Xenograft Bioprostheses,Xenograft Bioprostheses, Porcine,Xenograft Bioprosthesis, Porcine

Related Publications

Alessandra Francica, and Mikhail Dodonov, and Filippo Tonelli, and Gaetano Paolino, and Gabriele Pesarini, and Flavio Ribichini, and Giuseppe Faggian, and Francesco Onorati
Early transcatheter aortic valve thrombosis.
May 2013, Journal of cardiac surgery,
Alessandra Francica, and Mikhail Dodonov, and Filippo Tonelli, and Gaetano Paolino, and Gabriele Pesarini, and Flavio Ribichini, and Giuseppe Faggian, and Francesco Onorati
Pseudo early degeneration of a transcatheter aortic valve prosthesis due to thrombosis.
March 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,
Alessandra Francica, and Mikhail Dodonov, and Filippo Tonelli, and Gaetano Paolino, and Gabriele Pesarini, and Flavio Ribichini, and Giuseppe Faggian, and Francesco Onorati
Transcatheter Mitral Valve Prosthesis Dysfunction　- Early Valve Degeneration or Thrombosis?
July 2018, Circulation journal : official journal of the Japanese Circulation Society,
Alessandra Francica, and Mikhail Dodonov, and Filippo Tonelli, and Gaetano Paolino, and Gabriele Pesarini, and Flavio Ribichini, and Giuseppe Faggian, and Francesco Onorati
[Transcatheter aortic valve thrombosis].
December 2017, Annales de cardiologie et d'angeiologie,
Alessandra Francica, and Mikhail Dodonov, and Filippo Tonelli, and Gaetano Paolino, and Gabriele Pesarini, and Flavio Ribichini, and Giuseppe Faggian, and Francesco Onorati
Very Early Subclinical Valve Thrombosis After Transcatheter Aortic Valve Replacement.
November 2017, Circulation. Cardiovascular interventions,
Alessandra Francica, and Mikhail Dodonov, and Filippo Tonelli, and Gaetano Paolino, and Gabriele Pesarini, and Flavio Ribichini, and Giuseppe Faggian, and Francesco Onorati
Comparative analysis of early postoperative results of transcatheter aortic valve implantation and surgical aortic valve replacement with a biological prosthesis.
January 2024, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
Alessandra Francica, and Mikhail Dodonov, and Filippo Tonelli, and Gaetano Paolino, and Gabriele Pesarini, and Flavio Ribichini, and Giuseppe Faggian, and Francesco Onorati
Early restenosis of a direct flow transcatheter aortic valve prosthesis.
April 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,
Alessandra Francica, and Mikhail Dodonov, and Filippo Tonelli, and Gaetano Paolino, and Gabriele Pesarini, and Flavio Ribichini, and Giuseppe Faggian, and Francesco Onorati
[Early postoperative thrombolysis of Saint-Jude aortic valve prosthesis].
July 1992, Archives des maladies du coeur et des vaisseaux,
Alessandra Francica, and Mikhail Dodonov, and Filippo Tonelli, and Gaetano Paolino, and Gabriele Pesarini, and Flavio Ribichini, and Giuseppe Faggian, and Francesco Onorati
Influence of prosthesis-related factors on the occurrence of early leaflet thrombosis after transcatheter aortic valve implantation.
October 2020, European heart journal. Cardiovascular Imaging,
Alessandra Francica, and Mikhail Dodonov, and Filippo Tonelli, and Gaetano Paolino, and Gabriele Pesarini, and Flavio Ribichini, and Giuseppe Faggian, and Francesco Onorati
Valve Thrombosis After Transcatheter Aortic Valve Replacement.
March 2017, Journal of the American College of Cardiology,
Copied contents to your clipboard!